首页 > 最新文献

Journal of Bone Metabolism最新文献

英文 中文
Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial. 巴泽多昔芬/维生素D联合治疗对绝经后骨质减少妇女血清维生素D水平和骨转换标志物的影响:一项随机对照试验
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.11005/jbm.2023.30.2.189
Chaiho Jeong, Jeonghoon Ha, Jun-Il Yoo, Young-Kyun Lee, Jung Hee Kim, Yong-Chan Ha, Yong-Ki Min, Dong-Won Byun, Ki-Hyun Baek, Ho Yeon Chung

Background: This study aimed to evaluate the effectiveness of bazedoxifene/vitamin D combination therapy in preventing osteoporosis in postmenopausal women with osteopenia.

Methods: This was an open-label, multicenter randomized-controlled, phase 4 clinical trial. Women between ages of 55 and 70 years in 9 medical tertiary centers in Korea were enrolled and assigned into 2 groups: an experiment group and a control group. The experimental group received bazedoxifene 20 mg/vitamin D 800 IU tablets for 6 months, and the control group received calcium 100 mg/vitamin D 1,000 IU tablets for 6 months.

Results: A total of 142 patients (70 in the experimental group and 72 in the control group) were included. The least-square mean±standard error of change in propeptide of type I collagen after 3 months was -6.87±2.56% in the experimental group and 1.22±2.54% in the control group. After 6 months, it was -21.07±2.75% in the experimental group and 1.26±2.71% in the control group. The difference between the 2 groups was -22.33% (p<0.01). The change of C-terminal telopeptide was -12.55±4.05% in the experimental group and 11.02±4.03% in the control group after 3 months. It was -22.0±3.95% and 10.20±3.89, respectively, after 6 months. The difference between the 2 groups was -32.21% (p<0.01) after 6 months. There was no significant difference in adverse events between the 2 groups.

Conclusions: The osteoporosis preventive effect and safety of administering bazedoxifene/vitamin D combination pill were confirmed in postmenopausal women who needed osteoporosis prevention.

背景:本研究旨在评价巴泽多昔芬/维生素D联合治疗对绝经后骨质减少妇女骨质疏松症的预防效果。方法:这是一项开放标签、多中心随机对照的4期临床试验。在韩国9个医疗三级中心招募年龄在55 ~ 70岁的女性,并将其分为两组:实验组和对照组。实验组给予巴泽多昔芬20 mg/维生素D 800 IU片,疗程6个月,对照组给予钙100 mg/维生素D 1000 IU片,疗程6个月。结果:共纳入142例患者,其中实验组70例,对照组72例。3个月后I型胶原前肽变化的最小二乘平均值±标准误差实验组为-6.87±2.56%,对照组为1.22±2.54%。6个月后,实验组为-21.07±2.75%,对照组为1.26±2.71%。结论:对需要预防骨质疏松的绝经后妇女应用巴泽多昔芬/维生素D联合丸预防骨质疏松的效果和安全性得到证实。
{"title":"Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial.","authors":"Chaiho Jeong,&nbsp;Jeonghoon Ha,&nbsp;Jun-Il Yoo,&nbsp;Young-Kyun Lee,&nbsp;Jung Hee Kim,&nbsp;Yong-Chan Ha,&nbsp;Yong-Ki Min,&nbsp;Dong-Won Byun,&nbsp;Ki-Hyun Baek,&nbsp;Ho Yeon Chung","doi":"10.11005/jbm.2023.30.2.189","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.2.189","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the effectiveness of bazedoxifene/vitamin D combination therapy in preventing osteoporosis in postmenopausal women with osteopenia.</p><p><strong>Methods: </strong>This was an open-label, multicenter randomized-controlled, phase 4 clinical trial. Women between ages of 55 and 70 years in 9 medical tertiary centers in Korea were enrolled and assigned into 2 groups: an experiment group and a control group. The experimental group received bazedoxifene 20 mg/vitamin D 800 IU tablets for 6 months, and the control group received calcium 100 mg/vitamin D 1,000 IU tablets for 6 months.</p><p><strong>Results: </strong>A total of 142 patients (70 in the experimental group and 72 in the control group) were included. The least-square mean±standard error of change in propeptide of type I collagen after 3 months was -6.87±2.56% in the experimental group and 1.22±2.54% in the control group. After 6 months, it was -21.07±2.75% in the experimental group and 1.26±2.71% in the control group. The difference between the 2 groups was -22.33% (p<0.01). The change of C-terminal telopeptide was -12.55±4.05% in the experimental group and 11.02±4.03% in the control group after 3 months. It was -22.0±3.95% and 10.20±3.89, respectively, after 6 months. The difference between the 2 groups was -32.21% (p<0.01) after 6 months. There was no significant difference in adverse events between the 2 groups.</p><p><strong>Conclusions: </strong>The osteoporosis preventive effect and safety of administering bazedoxifene/vitamin D combination pill were confirmed in postmenopausal women who needed osteoporosis prevention.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 2","pages":"189-199"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/b4/jbm-2023-30-2-189.PMC10345998.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Bone Mineral Density, Trabecular Bone Score and Fractures in Patients Hospitalized for Heart Failure. 心力衰竭住院患者的骨质密度、骨小梁评分和骨折。
Q2 Medicine Pub Date : 2023-05-01 Epub Date: 2023-05-31 DOI: 10.11005/jbm.2023.30.2.167
Lucian Batista de Oliveira, Mariana Andrade de Figueiredo Martins Siqueira, Rafael Buarque de Macedo Gadêlha, Beatriz Pontes Barreto, Alice Rodrigues Pimentel Correia, Vinicius Belfort Leão, Jessica Garcia, Francisco Bandeira

Background: This study aimed to evaluate the bone mineral density (BMD), trabecular bone score (TBS), and fracture history of middle-aged patients hospitalized for heart failure (HF), as well as analyze the association of these factors with cardiometabolic parameters and muscle strength.

Methods: A cross-sectional study with patients aged 40 to 64 years hospitalized for HF was performed. Dual energy X-ray absorptiometry was performed to obtain BMD and TBS. Fracture history, handgrip strength (HGS), and clinical and laboratory cardiometabolic parameters of the patients were evaluated.

Results: Altogether, 109 patients were evaluated (female 50.5%). Medians and interquartile ranges for age and length of hospital stay were 58.0 (53.0-61.0) years and 20.0 (11.0-32.0) days, respectively. Osteoporosis was observed in 15.6% of the patients, low TBS was observed in 22.8%, and 6 patients had a history of fragile fracture. No differences between the sexes regarding BMD (p=0.335) or TBS (p=0.736) classifications were observed. No association was observed between low BMD and HF classification (p>0.05) regarding the ejection fraction, ischemic etiology, or New York Heart Association Functional Classification. However, there was a significant association between high serum parathyroid hormone (PTH) and the presence of osteoporosis (62.5 [37.2-119.0] pg/mL vs. 34.2 [25.0-54.1] pg/mL; p=0.016). There was a negative correlation between serum PTH and TBS (r=-0.329, p=0.038) and a higher frequency of reduced HGS in patients with low TBS (92.3% vs. 50.0%; p=0.009).

Conclusions: We found relevant frequencies of osteoporosis and bone microarchitecture degradation in middle-aged patients with HF, which were related to high serum PTH concentrations.

研究背景本研究旨在评估因心力衰竭(HF)住院的中年患者的骨矿密度(BMD)、骨小梁评分(TBS)和骨折史,并分析这些因素与心脏代谢参数和肌肉力量的关系:方法:对因心力衰竭住院的 40 至 64 岁患者进行横断面研究。采用双能 X 射线吸收测量法获得 BMD 和 TBS。对患者的骨折史、手握力(HGS)以及临床和实验室心血管代谢参数进行了评估:共评估了 109 名患者(女性占 50.5%)。年龄和住院时间的中位数和四分位数范围分别为 58.0(53.0-61.0)岁和 20.0(11.0-32.0)天。15.6%的患者有骨质疏松症,22.8%的患者有低TBS,6名患者有脆性骨折史。在 BMD(P=0.335)或 TBS(P=0.736)分类方面,未发现性别差异。在射血分数、缺血性病因或纽约心脏协会功能分类方面,未观察到低 BMD 与 HF 分类之间存在关联(p>0.05)。然而,血清甲状旁腺激素(PTH)偏高与骨质疏松症之间存在显著关联(62.5 [37.2-119.0] pg/mL vs. 34.2 [25.0-54.1] pg/mL;P=0.016)。血清 PTH 与 TBS 呈负相关(r=-0.329,p=0.038),低 TBS 患者 HGS 降低的频率更高(92.3% vs. 50.0%;p=0.009):我们发现,中年高血压患者骨质疏松症和骨微结构退化的发生率与血清 PTH 浓度高有关。
{"title":"Bone Mineral Density, Trabecular Bone Score and Fractures in Patients Hospitalized for Heart Failure.","authors":"Lucian Batista de Oliveira, Mariana Andrade de Figueiredo Martins Siqueira, Rafael Buarque de Macedo Gadêlha, Beatriz Pontes Barreto, Alice Rodrigues Pimentel Correia, Vinicius Belfort Leão, Jessica Garcia, Francisco Bandeira","doi":"10.11005/jbm.2023.30.2.167","DOIUrl":"10.11005/jbm.2023.30.2.167","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the bone mineral density (BMD), trabecular bone score (TBS), and fracture history of middle-aged patients hospitalized for heart failure (HF), as well as analyze the association of these factors with cardiometabolic parameters and muscle strength.</p><p><strong>Methods: </strong>A cross-sectional study with patients aged 40 to 64 years hospitalized for HF was performed. Dual energy X-ray absorptiometry was performed to obtain BMD and TBS. Fracture history, handgrip strength (HGS), and clinical and laboratory cardiometabolic parameters of the patients were evaluated.</p><p><strong>Results: </strong>Altogether, 109 patients were evaluated (female 50.5%). Medians and interquartile ranges for age and length of hospital stay were 58.0 (53.0-61.0) years and 20.0 (11.0-32.0) days, respectively. Osteoporosis was observed in 15.6% of the patients, low TBS was observed in 22.8%, and 6 patients had a history of fragile fracture. No differences between the sexes regarding BMD (p=0.335) or TBS (p=0.736) classifications were observed. No association was observed between low BMD and HF classification (p>0.05) regarding the ejection fraction, ischemic etiology, or New York Heart Association Functional Classification. However, there was a significant association between high serum parathyroid hormone (PTH) and the presence of osteoporosis (62.5 [37.2-119.0] pg/mL vs. 34.2 [25.0-54.1] pg/mL; p=0.016). There was a negative correlation between serum PTH and TBS (r=-0.329, p=0.038) and a higher frequency of reduced HGS in patients with low TBS (92.3% vs. 50.0%; p=0.009).</p><p><strong>Conclusions: </strong>We found relevant frequencies of osteoporosis and bone microarchitecture degradation in middle-aged patients with HF, which were related to high serum PTH concentrations.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 2","pages":"167-177"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/86/cb/jbm-2023-30-2-167.PMC10346004.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Hyperfunctioning Lipoadenoma Presenting as a Cystic Pararthyroid Lesion. 一例罕见的功能亢进脂肪腺瘤表现为囊性甲状旁腺病变。
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.11005/jbm.2023.30.2.201
Jinyoung Kim, Ohjoon Kwon, Tae-Jung Kim, So Lyung Jung, Eun Ji Han, Ki-Ho Song

A 58-year-old woman visited the hospital complaining of fatigue and indigestion lasting for more than 3 months. She had no medical history other than taking a calcium plus vitamin D supplement for osteopenia. The initial blood test showed a high calcium level of 14.0 mg/dL. Additional tests were performed to differentially diagnose hypercalcemia. The blood test results were as follows: serum parathyroid hormone (PTH)=247.0 pg/mL, PTH-related peptide <1.0 pg/mL, phosphorous=2.6 mg/dL, 25-hydroxy-vitamin D=14.5 pg/mL, creatinine=1.09 mg/dL, and 24 hr urine calcium=215 mg/dL. A 4.5 cm sized cystic lesion on the intra-thyroidal space was confirmed on neck sonography and 4-dimensional parathyroid computed tomography, but technetium-99m methoxyisobutylisonitrile parathyroid scintigraphy showed equivocal results. After removal of the cystic lesion, serum calcium and PTH were normalized, and parathyroid lipoadenoma was confirmed in the postoperative pathology. Clinical features of parathyroid lipoadenoma are known to be similar to common parathyroid adenoma, but imaging studies often report negative findings. Therefore, it is necessary to better understand this rare disease for the differential diagnosis. For the final diagnosis and treatment of this disease, parathyroidectomy with intraoperative PTH measurement may be required.

一名58岁妇女就诊,主诉疲劳和消化不良持续3个多月。除服用钙加维生素D补充剂治疗骨质减少症外,无其他病史。最初的血液检查显示钙含量高达14.0毫克/分升。进行其他试验以鉴别诊断高钙血症。血检结果如下:血清甲状旁腺激素(PTH)=247.0 pg/mL, PTH相关肽
{"title":"A Rare Case of Hyperfunctioning Lipoadenoma Presenting as a Cystic Pararthyroid Lesion.","authors":"Jinyoung Kim,&nbsp;Ohjoon Kwon,&nbsp;Tae-Jung Kim,&nbsp;So Lyung Jung,&nbsp;Eun Ji Han,&nbsp;Ki-Ho Song","doi":"10.11005/jbm.2023.30.2.201","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.2.201","url":null,"abstract":"<p><p>A 58-year-old woman visited the hospital complaining of fatigue and indigestion lasting for more than 3 months. She had no medical history other than taking a calcium plus vitamin D supplement for osteopenia. The initial blood test showed a high calcium level of 14.0 mg/dL. Additional tests were performed to differentially diagnose hypercalcemia. The blood test results were as follows: serum parathyroid hormone (PTH)=247.0 pg/mL, PTH-related peptide <1.0 pg/mL, phosphorous=2.6 mg/dL, 25-hydroxy-vitamin D=14.5 pg/mL, creatinine=1.09 mg/dL, and 24 hr urine calcium=215 mg/dL. A 4.5 cm sized cystic lesion on the intra-thyroidal space was confirmed on neck sonography and 4-dimensional parathyroid computed tomography, but technetium-99m methoxyisobutylisonitrile parathyroid scintigraphy showed equivocal results. After removal of the cystic lesion, serum calcium and PTH were normalized, and parathyroid lipoadenoma was confirmed in the postoperative pathology. Clinical features of parathyroid lipoadenoma are known to be similar to common parathyroid adenoma, but imaging studies often report negative findings. Therefore, it is necessary to better understand this rare disease for the differential diagnosis. For the final diagnosis and treatment of this disease, parathyroidectomy with intraoperative PTH measurement may be required.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 2","pages":"201-207"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/87/jbm-2023-30-2-201.PMC10346001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Position Statement: Exercise Guidelines for Osteoporosis Management and Fall Prevention in Osteoporosis Patients. 立场声明:骨质疏松症管理和预防骨质疏松症患者跌倒的运动指南。
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.11005/jbm.2023.30.2.149
Seongryu Bae, Seungyong Lee, Hyuntae Park, Yongin Ju, Seok-Ki Min, Jinkyung Cho, Hyojin Kim, Yong-Chan Ha, Yumie Rhee, Young-Pyo Kim, Changsun Kim

Background: The effectiveness of exercise for improving osteoporosis and fall prevention in patients diagnosed with osteoporosis or osteopenia has not been fully summarized. The Korean Society for Bone and Mineral Research and the Korean Society of Exercise Physiology has developed exercise guidelines for patients with osteoporosis or osteopenia and provide evidence-based recommendations.

Methods: A systematic review identified randomized controlled trials (RCT) assessing the effect of resistance, impact, balance, aerobic training, and physical activity in osteoporosis and osteopenia on bone quality, physical performance, quality of life, and fall prevention. PubMed, Embase, KoreaMed, and RISS were searched from January 2000 to August 2022. Ten key questions were established to review the evidence and formulate recommendations.

Results: The 50 RCTs reported that even with osteoporosis and osteopenia, resistance and impact training consistently maximized bone strength, improved body strength and balance, and eventually reduced fall incidences. Resistance exercise combining 3 to 10 types of free weight and mechanical exercise of major muscle groups performed with an intensity of 50% to 85% 1-repetition maximum, 5 to 12 repetitions/set, 2 to 3 days/week, for 3 to 12 months is recommended. Impact exercises such as jumping chin-ups with drop landings and jump rope performed 50 jumps/session for at least 6 months with 3 or more days/week are recommended.

Conclusions: A multi-component exercise mainly comprised of resistance and impact exercise seems to be an effective strategy to attenuate the risk factors of osteoporosis and osteopenia. The integration of exercise guidelines and individualized exercise plans has significant potential to reduce the morbidity and mortality of osteoporosis.

背景:在骨质疏松或骨质减少患者中,运动对改善骨质疏松和预防跌倒的有效性尚未得到充分的总结。韩国骨骼与矿物研究学会和韩国运动生理学学会为骨质疏松症或骨质减少症患者制定了运动指南,并提供了基于证据的建议。方法:一项系统综述确定了随机对照试验(RCT),评估骨质疏松症和骨质减少症患者的抵抗、冲击、平衡、有氧训练和身体活动对骨质量、身体表现、生活质量和预防跌倒的影响。PubMed、Embase、KoreaMed和RISS的检索时间为2000年1月至2022年8月。制定了十个关键问题,以审查证据并制定建议。结果:50项随机对照试验报告,即使骨质疏松和骨质减少,阻力和冲击训练也能持续最大化骨强度,改善身体力量和平衡,并最终减少跌倒发生率。阻力训练包括3 - 10种类型的自由重量和主要肌肉群的机械训练,强度为50% - 85%,最多重复1次,5 - 12次/组,每周2 - 3天,持续3 - 12个月。建议进行冲击性运动,如引体向上跳跃和跳绳,每次50次,每周3天或以上,至少6个月。结论:以阻力运动和冲击运动为主的多组分运动是减轻骨质疏松和骨质减少危险因素的有效策略。运动指南和个体化运动计划的整合对降低骨质疏松症的发病率和死亡率具有重要的潜力。
{"title":"Position Statement: Exercise Guidelines for Osteoporosis Management and Fall Prevention in Osteoporosis Patients.","authors":"Seongryu Bae,&nbsp;Seungyong Lee,&nbsp;Hyuntae Park,&nbsp;Yongin Ju,&nbsp;Seok-Ki Min,&nbsp;Jinkyung Cho,&nbsp;Hyojin Kim,&nbsp;Yong-Chan Ha,&nbsp;Yumie Rhee,&nbsp;Young-Pyo Kim,&nbsp;Changsun Kim","doi":"10.11005/jbm.2023.30.2.149","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.2.149","url":null,"abstract":"<p><strong>Background: </strong>The effectiveness of exercise for improving osteoporosis and fall prevention in patients diagnosed with osteoporosis or osteopenia has not been fully summarized. The Korean Society for Bone and Mineral Research and the Korean Society of Exercise Physiology has developed exercise guidelines for patients with osteoporosis or osteopenia and provide evidence-based recommendations.</p><p><strong>Methods: </strong>A systematic review identified randomized controlled trials (RCT) assessing the effect of resistance, impact, balance, aerobic training, and physical activity in osteoporosis and osteopenia on bone quality, physical performance, quality of life, and fall prevention. PubMed, Embase, KoreaMed, and RISS were searched from January 2000 to August 2022. Ten key questions were established to review the evidence and formulate recommendations.</p><p><strong>Results: </strong>The 50 RCTs reported that even with osteoporosis and osteopenia, resistance and impact training consistently maximized bone strength, improved body strength and balance, and eventually reduced fall incidences. Resistance exercise combining 3 to 10 types of free weight and mechanical exercise of major muscle groups performed with an intensity of 50% to 85% 1-repetition maximum, 5 to 12 repetitions/set, 2 to 3 days/week, for 3 to 12 months is recommended. Impact exercises such as jumping chin-ups with drop landings and jump rope performed 50 jumps/session for at least 6 months with 3 or more days/week are recommended.</p><p><strong>Conclusions: </strong>A multi-component exercise mainly comprised of resistance and impact exercise seems to be an effective strategy to attenuate the risk factors of osteoporosis and osteopenia. The integration of exercise guidelines and individualized exercise plans has significant potential to reduce the morbidity and mortality of osteoporosis.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 2","pages":"149-165"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/74/c0/jbm-2023-30-2-149.PMC10345999.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Origin of Osteoclasts: Osteoclast Precursor Cells. 破骨细胞的起源破骨细胞前体细胞。
Q2 Medicine Pub Date : 2023-05-01 Epub Date: 2023-05-31 DOI: 10.11005/jbm.2023.30.2.127
Jefferson Tsai, Kaichi Kaneko, Andrew J Suh, Richard Bockman, Kyung-Hyun Park-Min

Osteoclasts are multinucleated bone-resorbing cells and a key player in bone remodeling for health and disease. Since the discovery of osteoclasts in 1873, the structure and function of osteoclasts and the molecular and cellular mechanisms of osteoclastogenesis have been extensively studied. Moreover, it has been well established that osteoclasts are differentiated in vitro from myeloid cells such as bone marrow macrophages or monocytes. The concept showing that osteoclasts are derived from a specific population (named osteoclast precursor cells [OCPs]) among myeloid cells has been long hypothesized. However, the specific precursor population of osteoclasts is not clearly defined yet. A growing body of work provides evidence of the developmental origin and lifespan of murine osteoclasts, particularly in vivo. Here, we review the emerging evidence that supports the existence of OCPs and discuss current insights into their identity.

破骨细胞是多核的骨吸收细胞,是健康和疾病骨重塑的关键角色。自 1873 年发现破骨细胞以来,人们对破骨细胞的结构和功能以及破骨细胞生成的分子和细胞机制进行了广泛研究。此外,破骨细胞是由骨髓巨噬细胞或单核细胞等髓系细胞在体外分化而来,这一点已得到充分证实。破骨细胞来源于髓系细胞中的一个特定群体(被命名为破骨细胞前体细胞 [OCPs]),这一概念的提出由来已久。然而,破骨细胞的特定前体细胞群尚未明确定义。越来越多的研究证明了小鼠破骨细胞的发育起源和寿命,尤其是在体内。在此,我们回顾了支持破骨细胞存在的新证据,并讨论了目前对其特性的见解。
{"title":"Origin of Osteoclasts: Osteoclast Precursor Cells.","authors":"Jefferson Tsai, Kaichi Kaneko, Andrew J Suh, Richard Bockman, Kyung-Hyun Park-Min","doi":"10.11005/jbm.2023.30.2.127","DOIUrl":"10.11005/jbm.2023.30.2.127","url":null,"abstract":"<p><p>Osteoclasts are multinucleated bone-resorbing cells and a key player in bone remodeling for health and disease. Since the discovery of osteoclasts in 1873, the structure and function of osteoclasts and the molecular and cellular mechanisms of osteoclastogenesis have been extensively studied. Moreover, it has been well established that osteoclasts are differentiated in vitro from myeloid cells such as bone marrow macrophages or monocytes. The concept showing that osteoclasts are derived from a specific population (named osteoclast precursor cells [OCPs]) among myeloid cells has been long hypothesized. However, the specific precursor population of osteoclasts is not clearly defined yet. A growing body of work provides evidence of the developmental origin and lifespan of murine osteoclasts, particularly in vivo. Here, we review the emerging evidence that supports the existence of OCPs and discuss current insights into their identity.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 2","pages":"127-140"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/82/jbm-2023-30-2-127.PMC10346003.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Vitamin B6 on Osteoporosis Fracture. 维生素B6对骨质疏松骨折的影响。
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.11005/jbm.2023.30.2.141
Rahmani Welan

Osteoporosis is a medical condition that causes bones to become weak and brittle, making them more likely to break or fracture. This condition occurs when the body loses too much bone, makes too little bone, or both. Bones are living tissues that are constantly being broken down and rebuilt. However, as we age, this process slows down, and our bodies may be unable to replace bone as quickly as it is broken down. This can lead to a loss of bone density, making bones weaker and more prone to fracture. Unfortunately, osteoporosis often has no symptoms until a bone is broken, so taking steps to prevent this condition is essential. This may include getting enough calcium and vitamin D, engaging in weight-bearing exercise, quitting smoking, limiting alcohol intake, and taking medication if prescribed by a doctor. Vitamin B6, also known as pyridoxine, is a water-soluble vitamin that plays a vital role in various bodily functions. It is part of the B-vitamin complex and is essential for metabolizing proteins, carbohydrates, and fats. Vitamin B6 produces neurotransmitters such as serotonin, which helps regulate mood, and dopamine, which is involved in motivation and reward. Several previous studies have found that women with higher intakes of vitamin B6 have higher bone mineral density (BMD) of the hips and spine than women with lower intakes. Another study found that men and women with higher blood levels of vitamin B6 had higher BMD in the hips and spine.

骨质疏松症是一种导致骨骼变得脆弱和易碎的医学疾病,使它们更容易断裂或骨折。这种情况发生时,身体失去太多的骨头,太少的骨头,或两者兼而有之。骨头是不断被分解和重建的活组织。然而,随着年龄的增长,这个过程变慢了,我们的身体可能无法像骨头分解那样快速地替换骨头。这会导致骨密度下降,使骨骼变弱,更容易骨折。不幸的是,骨质疏松症通常在骨折之前没有症状,所以采取措施预防这种情况是必不可少的。这可能包括摄入足够的钙和维生素D,进行负重运动,戒烟,限制酒精摄入量,并根据医生的处方服用药物。维生素B6,也被称为吡哆醇,是一种水溶性维生素,在各种身体功能中起着至关重要的作用。它是b族维生素复合物的一部分,是代谢蛋白质、碳水化合物和脂肪所必需的。维生素B6产生神经递质,如帮助调节情绪的血清素和与动机和奖励有关的多巴胺。之前的几项研究发现,摄入维生素B6较多的女性髋部和脊柱的骨密度(BMD)高于摄入量较少的女性。另一项研究发现,血液中维生素B6含量较高的男性和女性,臀部和脊柱的骨密度也较高。
{"title":"Effect of Vitamin B6 on Osteoporosis Fracture.","authors":"Rahmani Welan","doi":"10.11005/jbm.2023.30.2.141","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.2.141","url":null,"abstract":"<p><p>Osteoporosis is a medical condition that causes bones to become weak and brittle, making them more likely to break or fracture. This condition occurs when the body loses too much bone, makes too little bone, or both. Bones are living tissues that are constantly being broken down and rebuilt. However, as we age, this process slows down, and our bodies may be unable to replace bone as quickly as it is broken down. This can lead to a loss of bone density, making bones weaker and more prone to fracture. Unfortunately, osteoporosis often has no symptoms until a bone is broken, so taking steps to prevent this condition is essential. This may include getting enough calcium and vitamin D, engaging in weight-bearing exercise, quitting smoking, limiting alcohol intake, and taking medication if prescribed by a doctor. Vitamin B6, also known as pyridoxine, is a water-soluble vitamin that plays a vital role in various bodily functions. It is part of the B-vitamin complex and is essential for metabolizing proteins, carbohydrates, and fats. Vitamin B6 produces neurotransmitters such as serotonin, which helps regulate mood, and dopamine, which is involved in motivation and reward. Several previous studies have found that women with higher intakes of vitamin B6 have higher bone mineral density (BMD) of the hips and spine than women with lower intakes. Another study found that men and women with higher blood levels of vitamin B6 had higher BMD in the hips and spine.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 2","pages":"141-147"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bb/cb/jbm-2023-30-2-141.PMC10346000.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9813958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trabecular Bone Score and Central Quantitative Computed Tomography for the Prediction of Vertebral Fragility Fractures in Postmenopausal Women. 小梁骨评分和中央定量计算机断层扫描预测绝经后妇女椎体脆性骨折。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.11005/jbm.2023.30.1.77
Soree Ryang, Yun Kyung Jeon, Tae Sik Goh, In-Joo Kim, Keunyoung Kim

Background: We aimed to investigate whether densitometry results and volumetric bone mineral density (vBMD) can predict vertebral fragility fractures (VFF) in postmenopausal women.

Methods: We enrolled 271 postmenopausal women aged >45 years who visited our hospital for health check-ups between September 2016 and September 2017. The lumbar spine (LS) and femoral neck (FN) densitometry results and trabecular bone score (TBS) were calculated using dual energy X-ray absorptiometry. vBMD was assessed using central quantitative computed tomography (cQCT). Baseline and follow-up X-ray images were reviewed to evaluate thoracolumbar vertebral compression fractures (CFs), according to the Genant criteria.

Results: At baseline, 76 patients (28.0%) had CF. Additional or progressive fractures were noted in 26 participants (9.6%) with a median follow-up of 19.5 months. The median TBS and cQCT were significantly higher in participants without baseline CF than those with baseline CF (p<0.001). During the follow-up, Kaplan-Meier analysis showed that T-scores of the LS and FN <-2.5, degraded microarchitecture based on the TBS (≤1.200), and vBMD <80 mg/cm3 was significantly associated with future osteoporotic CF. The final multivariate Cox regression analysis showed that baseline CF and low TBS and vBMD were significant risk factors for future VFF.

Conclusions: Participants with baseline CF and degraded microarchitecture had higher CF predisposition. Moreover, cQCT can predict future vertebral fractures.

背景:我们的目的是研究密度测量结果和体积骨密度(vBMD)是否可以预测绝经后妇女椎体脆性骨折(VFF)。方法:选取2016年9月至2017年9月至我院进行健康检查的绝经后妇女271例,年龄>45岁。采用双能x线骨密度仪计算腰椎(LS)和股骨颈(FN)密度测定结果和骨小梁评分(TBS)。采用中央定量计算机断层扫描(cQCT)评估vBMD。根据Genant标准,回顾基线和随访x线图像以评估胸腰椎压缩性骨折(CFs)。结果:基线时,76名患者(28.0%)患有CF。26名参与者(9.6%)出现额外或进行性骨折,中位随访时间为19.5个月。无基线CF的参与者的中位TBS和cQCT显著高于基线CF的参与者(结论:基线CF和微结构退化的参与者有更高的CF易感。此外,cQCT可以预测未来的椎体骨折。
{"title":"Trabecular Bone Score and Central Quantitative Computed Tomography for the Prediction of Vertebral Fragility Fractures in Postmenopausal Women.","authors":"Soree Ryang,&nbsp;Yun Kyung Jeon,&nbsp;Tae Sik Goh,&nbsp;In-Joo Kim,&nbsp;Keunyoung Kim","doi":"10.11005/jbm.2023.30.1.77","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.1.77","url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate whether densitometry results and volumetric bone mineral density (vBMD) can predict vertebral fragility fractures (VFF) in postmenopausal women.</p><p><strong>Methods: </strong>We enrolled 271 postmenopausal women aged >45 years who visited our hospital for health check-ups between September 2016 and September 2017. The lumbar spine (LS) and femoral neck (FN) densitometry results and trabecular bone score (TBS) were calculated using dual energy X-ray absorptiometry. vBMD was assessed using central quantitative computed tomography (cQCT). Baseline and follow-up X-ray images were reviewed to evaluate thoracolumbar vertebral compression fractures (CFs), according to the Genant criteria.</p><p><strong>Results: </strong>At baseline, 76 patients (28.0%) had CF. Additional or progressive fractures were noted in 26 participants (9.6%) with a median follow-up of 19.5 months. The median TBS and cQCT were significantly higher in participants without baseline CF than those with baseline CF (p<0.001). During the follow-up, Kaplan-Meier analysis showed that T-scores of the LS and FN <-2.5, degraded microarchitecture based on the TBS (≤1.200), and vBMD <80 mg/cm3 was significantly associated with future osteoporotic CF. The final multivariate Cox regression analysis showed that baseline CF and low TBS and vBMD were significant risk factors for future VFF.</p><p><strong>Conclusions: </strong>Participants with baseline CF and degraded microarchitecture had higher CF predisposition. Moreover, cQCT can predict future vertebral fractures.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 1","pages":"77-86"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6f/24/jbm-2023-30-1-77.PMC10036180.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9252181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Melatonin Protects Bone Microarchitecture against Deterioration due to High-Fat Diet-Induced Obesity. 褪黑素保护骨微结构免受高脂肪饮食引起的肥胖的恶化。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.11005/jbm.2023.30.1.69
Bukyung Kim, Yeon Ji Kim, Jae Hyun Kim, Kwangkuk Park, Hyungjune Ku, Young-Sik Choi

Background: We evaluated the protective effects of melatonin against high-fat diet (HFD)-induced deterioration of bone microarchitecture using high-resolution peripheral quantitative computed tomography (HR-pQCT).

Methods: Four-week-old male C57BL/6 mice were divided into control (chow diet group), HFD, and HFD + melatonin-administered groups. Mice were sacrificed after 14 weeks, and the right femur was extracted. The microskeletal structure of the femur was analyzed using SkyScan1173 (version 1.6). A 3-dimensional image was reconstructed using the Nrecon (version 1.7.0.4) program.

Results: Bone volume (BV) was significantly increased in the HFD group compared with that in the normal diet group, and that of the melatonin group also increased significantly compared with BV of the normal diet group (p<0.05). Percent BV/total volume [TV] and bone surface/BV were significantly higher in both the HFD and melatonin groups than in the normal diet group (p<0.05), and the melatonin group had the highest BV/total volume (TV). BMD was lower in the HFD than in the normal diet group and was the highest in the melatonin group.

Conclusions: This study shows that melatonin inhibited the deterioration of microarchitecture induced by a HFD. A better understanding of the protective effect of melatonin on bone microarchitecture and mechanisms could provide fracture prevention for people who are obese.

背景:我们使用高分辨率外周定量计算机断层扫描(HR-pQCT)评估褪黑激素对高脂肪饮食(HFD)引起的骨微结构恶化的保护作用。方法:将4周龄雄性C57BL/6小鼠分为对照组(鼠粮组)、HFD组和HFD +褪黑素组。14周后处死小鼠,取出右侧股骨。使用SkyScan1173(1.6版)分析股骨的微骨骼结构。使用Nrecon(版本1.7.0.4)程序重建三维图像。结果:与正常饮食组相比,HFD组骨体积(Bone volume, BV)显著增加,褪黑激素组骨体积(Bone volume, BV)与正常饮食组相比,褪黑激素组骨体积(Bone volume, BV)显著增加(p)结论:本研究表明,褪黑激素对HFD诱导的微结构恶化具有抑制作用。更好地了解褪黑素对骨微结构的保护作用及其机制,可以为肥胖人群预防骨折提供帮助。
{"title":"Melatonin Protects Bone Microarchitecture against Deterioration due to High-Fat Diet-Induced Obesity.","authors":"Bukyung Kim,&nbsp;Yeon Ji Kim,&nbsp;Jae Hyun Kim,&nbsp;Kwangkuk Park,&nbsp;Hyungjune Ku,&nbsp;Young-Sik Choi","doi":"10.11005/jbm.2023.30.1.69","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.1.69","url":null,"abstract":"<p><strong>Background: </strong>We evaluated the protective effects of melatonin against high-fat diet (HFD)-induced deterioration of bone microarchitecture using high-resolution peripheral quantitative computed tomography (HR-pQCT).</p><p><strong>Methods: </strong>Four-week-old male C57BL/6 mice were divided into control (chow diet group), HFD, and HFD + melatonin-administered groups. Mice were sacrificed after 14 weeks, and the right femur was extracted. The microskeletal structure of the femur was analyzed using SkyScan1173 (version 1.6). A 3-dimensional image was reconstructed using the Nrecon (version 1.7.0.4) program.</p><p><strong>Results: </strong>Bone volume (BV) was significantly increased in the HFD group compared with that in the normal diet group, and that of the melatonin group also increased significantly compared with BV of the normal diet group (p<0.05). Percent BV/total volume [TV] and bone surface/BV were significantly higher in both the HFD and melatonin groups than in the normal diet group (p<0.05), and the melatonin group had the highest BV/total volume (TV). BMD was lower in the HFD than in the normal diet group and was the highest in the melatonin group.</p><p><strong>Conclusions: </strong>This study shows that melatonin inhibited the deterioration of microarchitecture induced by a HFD. A better understanding of the protective effect of melatonin on bone microarchitecture and mechanisms could provide fracture prevention for people who are obese.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 1","pages":"69-75"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/82/jbm-2023-30-1-69.PMC10036183.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9252019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Seasonal Variations and Common Places of Hip Fractures in Elderly Patients: Nine Year Consecutive Survey. 老年患者髋部骨折的季节变化及常见部位:连续9年的调查。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.11005/jbm.2023.30.1.103
Kyung-A Choi, Yong-Chan Ha, Kyung-Hag Lee

Background: Fall prevention is important for reducing hip fractures. The aim of this study was to determine the relationship between variables related to hip fractures according to sex and season.

Methods: This study included patients admitted for fragility hip fractures between 2012 and 2021. Patients were interviewed by a junior resident before discharge. Data on sex, age, diagnosis, osteoporosis treatment, direction, voiding problems, ambulatory function, seasons, weather, time of day, place, location, floor condition, activity during fall, and perceived reason for fall were collected and analyzed.

Results: A total of 1,118 patients were included (279 males and 839 females). In both sexes, indoor falls were prevalent throughout all seasons, but males showed a higher proportion of outdoor falls, especially in winter during cloudy or snowy weather. Rooms and walking were the most common locations and activities during falls. The poor ambulatory function was associated with a higher prevalence of indoor falls. Osteoporosis treatment rates were low and did not differ according to Koval stage. Winter was associated with higher osteoporosis non-treatment group. Urgency/incontinence in female patients caused a higher proportion of falls during the evening time.

Conclusions: Strategies for indoor fall prevention and vigilant osteoporosis diagnosis and treatment are important for all seasons, especially for frail elderly patients. Outdoor fall prevention emphasized for male patients, and education around nighttime falls should be provided for female patients with voiding dysfunction.

背景:预防跌倒对减少髋部骨折很重要。本研究的目的是根据性别和季节确定与髋部骨折相关的变量之间的关系。方法:本研究纳入了2012年至2021年间因脆性髋部骨折入院的患者。出院前由初级住院医师对患者进行面谈。收集和分析性别、年龄、诊断、骨质疏松治疗、方向、排尿问题、行走功能、季节、天气、一天中的时间、地点、位置、地板状况、跌倒时的活动和跌倒的感知原因等数据。结果:共纳入1118例患者,其中男性279例,女性839例。在两性中,室内跌倒在所有季节都很普遍,但男性在室外跌倒的比例更高,特别是在冬季多云或下雪的天气。房间和散步是跌倒时最常见的地点和活动。运动功能差与室内跌倒的发生率较高有关。骨质疏松症的治愈率低,且Koval分期无差异。冬季未治疗组骨质疏松率较高。女性患者的尿急/尿失禁在晚间导致较高比例的跌倒。结论:室内预防跌倒和警惕骨质疏松症的诊断和治疗策略在任何季节都是重要的,特别是对年老体弱的患者。男性患者应加强户外跌倒预防,女性患者应加强夜间跌倒教育。
{"title":"Seasonal Variations and Common Places of Hip Fractures in Elderly Patients: Nine Year Consecutive Survey.","authors":"Kyung-A Choi,&nbsp;Yong-Chan Ha,&nbsp;Kyung-Hag Lee","doi":"10.11005/jbm.2023.30.1.103","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.1.103","url":null,"abstract":"<p><strong>Background: </strong>Fall prevention is important for reducing hip fractures. The aim of this study was to determine the relationship between variables related to hip fractures according to sex and season.</p><p><strong>Methods: </strong>This study included patients admitted for fragility hip fractures between 2012 and 2021. Patients were interviewed by a junior resident before discharge. Data on sex, age, diagnosis, osteoporosis treatment, direction, voiding problems, ambulatory function, seasons, weather, time of day, place, location, floor condition, activity during fall, and perceived reason for fall were collected and analyzed.</p><p><strong>Results: </strong>A total of 1,118 patients were included (279 males and 839 females). In both sexes, indoor falls were prevalent throughout all seasons, but males showed a higher proportion of outdoor falls, especially in winter during cloudy or snowy weather. Rooms and walking were the most common locations and activities during falls. The poor ambulatory function was associated with a higher prevalence of indoor falls. Osteoporosis treatment rates were low and did not differ according to Koval stage. Winter was associated with higher osteoporosis non-treatment group. Urgency/incontinence in female patients caused a higher proportion of falls during the evening time.</p><p><strong>Conclusions: </strong>Strategies for indoor fall prevention and vigilant osteoporosis diagnosis and treatment are important for all seasons, especially for frail elderly patients. Outdoor fall prevention emphasized for male patients, and education around nighttime falls should be provided for female patients with voiding dysfunction.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 1","pages":"103-114"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/14/jbm-2023-30-1-103.PMC10036185.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9252186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different Pattern of T-Score Discordance between Patients with Atypical Femoral Fracture and Femur Neck Fracture. 非典型股骨骨折与股骨颈骨折患者t评分不一致的不同模式。
Q2 Medicine Pub Date : 2023-02-01 DOI: 10.11005/jbm.2023.30.1.87
Byung-Ho Yoon, Jang-Won Park, Chan Woo Lee, Young Do Koh

Background: Our study evaluated the prevalence and pattern of T-score discordance between the spine and hip in Korean patients with atypical femoral fracture (AFF) and femur neck fracture (FNF).

Methods: A total of 49 patients (all women) who were treated for AFF and 1:3 matched 147 female patients with FNF were included from January 2012 to August 2022. A discordance of more than 1.5 between lumbar spine and femur neck bone mineral density (BMD) was defined as a difference and divided into 3 groups: lumbar low (LL; lumbar BMD is less than femur neck BMD), no discordance (ND), and femur neck low (FL; femur neck BMD is less than lumbar BMD). We compared the prevalence and pattern of discordance between 2 groups, and the associated risk factors of T-score discordance among the subjects were evaluated using regression analysis.

Results: The prevalence of discordance was significantly higher in patients with AFF (51%) than in those with FNF (25.2%; p<0.001). LL discordance was found in 46.9% of the patients with AFF but only 4.8% in those with FNF. Conversely, FL discordance was found in 4.1% of the patients with AFF and 20.4% in those with FNF, respectively. No specific risk factor was found as T-score discordance in the 2 groups.

Conclusions: Clinicians should be aware that the pattern of T-score discordance can vary depending on the location of osteoporotic fractures. In addition, a longitudinal study would be necessary to verify the pattern of T-score discordance related to the osteoporotic fracture location.

背景:我们的研究评估了韩国非典型股骨骨折(AFF)和股骨颈骨折(FNF)患者脊柱和髋部t评分不一致的患病率和模式。方法:2012年1月至2022年8月共纳入49例AFF患者(均为女性)和1:3匹配的147例女性FNF患者。将腰椎与股骨颈骨密度(BMD)差异大于1.5定义为差异,并分为3组:腰椎低(LL;腰椎骨密度小于股骨颈骨密度),无不一致(ND),股骨颈低(FL;股骨颈骨密度小于腰椎骨密度)。比较两组间t评分不一致的发生率和模式,并采用回归分析评估受试者间t评分不一致的相关危险因素。结果:AFF患者的不一致性患病率(51%)明显高于FNF患者(25.2%);结论:临床医生应该意识到,t评分不一致的模式可能因骨质疏松性骨折的位置而异。此外,有必要进行纵向研究来验证与骨质疏松性骨折位置相关的t评分不一致模式。
{"title":"Different Pattern of T-Score Discordance between Patients with Atypical Femoral Fracture and Femur Neck Fracture.","authors":"Byung-Ho Yoon,&nbsp;Jang-Won Park,&nbsp;Chan Woo Lee,&nbsp;Young Do Koh","doi":"10.11005/jbm.2023.30.1.87","DOIUrl":"https://doi.org/10.11005/jbm.2023.30.1.87","url":null,"abstract":"<p><strong>Background: </strong>Our study evaluated the prevalence and pattern of T-score discordance between the spine and hip in Korean patients with atypical femoral fracture (AFF) and femur neck fracture (FNF).</p><p><strong>Methods: </strong>A total of 49 patients (all women) who were treated for AFF and 1:3 matched 147 female patients with FNF were included from January 2012 to August 2022. A discordance of more than 1.5 between lumbar spine and femur neck bone mineral density (BMD) was defined as a difference and divided into 3 groups: lumbar low (LL; lumbar BMD is less than femur neck BMD), no discordance (ND), and femur neck low (FL; femur neck BMD is less than lumbar BMD). We compared the prevalence and pattern of discordance between 2 groups, and the associated risk factors of T-score discordance among the subjects were evaluated using regression analysis.</p><p><strong>Results: </strong>The prevalence of discordance was significantly higher in patients with AFF (51%) than in those with FNF (25.2%; p<0.001). LL discordance was found in 46.9% of the patients with AFF but only 4.8% in those with FNF. Conversely, FL discordance was found in 4.1% of the patients with AFF and 20.4% in those with FNF, respectively. No specific risk factor was found as T-score discordance in the 2 groups.</p><p><strong>Conclusions: </strong>Clinicians should be aware that the pattern of T-score discordance can vary depending on the location of osteoporotic fractures. In addition, a longitudinal study would be necessary to verify the pattern of T-score discordance related to the osteoporotic fracture location.</p>","PeriodicalId":15070,"journal":{"name":"Journal of Bone Metabolism","volume":"30 1","pages":"87-92"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/e8/jbm-2023-30-1-87.PMC10036188.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9252018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Bone Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1